Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00588029 · ClinicalTrials.gov registry record

Collection of Tissue, Blood, and Cells to Be Used For Studying the Causes, Prevention, Diagnosis, and Treatment of Breast Cancer

A clinical trial of Breast Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

Active
Registry status
7,000
Enrollment target
3
Study locations

NCT00588029: Active study of Breast Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00588029 is a study of Breast Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 7,000 participants, above the 2,798-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (150% higher). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00588029, a study of Breast Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.

ACTIVE NOT RECRUITING
Registry status
7,000 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to collect a blood sample from patients with breast disease (cases) and from individuals without breast cancer (controls)that may be used for research purposes. These blood samples will be used by researchers at Memorial Sloan-Kettering Cancer Center who study the causes of breast cancer, as well as more effective ways to prevent, diagnose, and treat breast cancer.

Conditions Studied

Breast Cancer

Study Locations (3)

New York

  • Memorial Sloan-Kettering Cancer Center @ Suffolk - Commack
  • Memorial Sloan-Kettering Cancer - New York

New Jersey

  • Memorial Sloan Kettering Cancer Center - Basking Ridge

Trial Details

FieldValue
Enrollment Target 7,000 participants
Start Date 1999-07
Est. Completion 2026-12
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the registry record for NCT00588029 still lists

NCT00588029 is an observational study that tracks outcomes without assigning an intervention. Its 7,000 participants enrollment target places it among the larger protocols in the corpus, above the 2,798-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (150% higher).

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.

NCT00588029 reports a single indexed study location in New York, New Jersey.

Frequently Asked Questions

What is clinical trial NCT00588029 about?

NCT00588029 is a clinical study titled "Collection of Tissue, Blood, and Cells to Be Used For Studying the Causes, Prevention, Diagnosis, and Treatment of Breast Cancer". The purpose of this study is to collect a blood sample from patients with breast disease (cases) and from individuals without breast cancer (controls)that may be used for research purposes. These blood samples will be used by researchers at Memorial Sloan-Kettering Cancer Center who study the causes...

What is the current status of trial NCT00588029?

This trial is currently active not recruiting. The enrollment target is 7,000 participants. The study started on 1999-07. Estimated completion is 2026-12.

What conditions does trial NCT00588029 study?

This clinical trial studies the following conditions: Breast Cancer.

Who is sponsoring clinical trial NCT00588029?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00588029 being conducted?

This trial has 3 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00588029's enrollment target sits among peer trials

7,000 22nd of 1224 higher than 1,202 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00260585 · 7,000 participants

    Esophageal Cancer Risk Registry

  • NCT04118660 · 7,000 participants

    Thoracic Specimen Registry

  • NCT07106879 · 7,000 participants

    Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.

  • NCT07140744 · 7,000 participants · NA

    A Study Evaluating the Impact of P-tau217 Blood Biomarker Testing on Early Evaluation and Management of Patients Presenting With Cognitive Complaint

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT00588029, the US trial registry maintained by the National Library of Medicine. NCT00588029 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.